Literature DB >> 17597113

Nuclear androgen receptors recur in the epithelial and stromal compartments of malignant and non-malignant human prostate tissue several months after castration therapy.

Pernilla Wikström1, Nina Ohlson, Pär Stattin, Anders Bergh.   

Abstract

BACKGROUND: As changed paracrine support from androgen receptor (AR)-positive cells in the prostate stroma contribute to castration-induced glandular involution, we examined if the subsequent relapse to androgen-independent epithelial cell growth could be related to reactivation of AR signaling in the stroma.
MATERIALS AND METHODS: Human prostate tissue taken before, within 14 days, and at suspected local tumor relapse after surgical castration therapy was immunostained for AR.
RESULTS: Castration initially decreased nuclear AR staining in epithelial and stroma cells, in both tumor and non-malignant tissue, but after some months, it reappeared.
CONCLUSIONS: Local tumor relapse was associated with reappearance of nuclear AR not only in tumor epithelial cells but also in the tumor stroma. Reappearance of nuclear AR in non-malignant prostate cells may be a physiological response to long-term systemic androgen ablation that could influence tumor growth.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17597113     DOI: 10.1002/pros.20569

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  8 in total

1.  Mast cells are novel independent prognostic markers in prostate cancer and represent a target for therapy.

Authors:  Anna Johansson; Stina Rudolfsson; Peter Hammarsten; Sofia Halin; Kristian Pietras; Jonathan Jones; Pär Stattin; Lars Egevad; Torvald Granfors; Pernilla Wikström; Anders Bergh
Journal:  Am J Pathol       Date:  2010-07-08       Impact factor: 4.307

Review 2.  Stroma-epithelium crosstalk in prostate cancer.

Authors:  Yi-Nong Niu; Shu-Jie Xia
Journal:  Asian J Androl       Date:  2008-12-22       Impact factor: 3.285

3.  Androgen regulation of epithelial-mesenchymal transition in prostate tumorigenesis.

Authors:  Emily A Matuszak; Natasha Kyprianou
Journal:  Expert Rev Endocrinol Metab       Date:  2011-05

4.  Cell-autonomous intracellular androgen receptor signaling drives the growth of human prostate cancer initiating cells.

Authors:  Donald J Vander Griend; Jason D'Antonio; Bora Gurel; Lizamma Antony; Angelo M Demarzo; John T Isaacs
Journal:  Prostate       Date:  2010-01-01       Impact factor: 4.104

Review 5.  [Pathophysiology and therapy of benign prostatic hyperplasia].

Authors:  Natalie Sampson; Stephan Madersbacher; Peter Berger
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

Review 6.  Clinical relevance of androgen receptor alterations in prostate cancer.

Authors:  Emma Jernberg; Anders Bergh; Pernilla Wikström
Journal:  Endocr Connect       Date:  2017-11       Impact factor: 3.335

7.  Conversion of androgen receptor signaling from a growth suppressor in normal prostate epithelial cells to an oncogene in prostate cancer cells involves a gain of function in c-Myc regulation.

Authors:  Donald J Vander Griend; Ivan V Litvinov; John T Isaacs
Journal:  Int J Biol Sci       Date:  2014-06-10       Impact factor: 6.580

8.  Intensity of stromal changes is associated with tumor relapse in clinically advanced prostate cancer after castration therapy.

Authors:  Jian-Ping Wu; Wen-Bin Huang; Hui Zhou; Lu-Wei Xu; Jian-Hua Zhao; Jia-Gen Zhu; Jiang-Hao Su; Hong-Bin Sun
Journal:  Asian J Androl       Date:  2014 Sep-Oct       Impact factor: 3.285

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.